Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (191-200 of 453) with videos related to

Pageof 46
Sort By:
Leukemia & Lymphoma|June 5, 2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLakshmi Nayak, Lauren E Abrey, Jan Drappatz, et al.
Neuro-Oncology|June 3, 2024
Raman-based machine-learning platform reveals unique metabolic differences between IDHmut and IDHwt gliomaAdrian Lita, Joel Sjöberg, David Păcioianu, et al.
Neuro-Oncology Practice|August 7, 2019
Case-based review: ependymomas in adultsDavid Cachia, Derek R Johnson, Timothy J Kaufmann, et al.
Neuro-Oncology Practice|June 3, 2015
Personal health records, symptoms, uncertainty, and mood in brain tumor patientsJennifer E Cahill, Lin Lin, Geri LoBiondo-Wood, et al.
Journal of Neuro-Oncology|August 24, 2015
Wound healing complications in brain tumor patients on BevacizumabHarshad Ladha, Tushar Pawar, Mark R Gilbert, et al.
Neuro-Oncology|April 12, 2015
The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-ChronicTerri S Armstrong, Yuan Ying, Jimin Wu, et al.
Neuro-Oncology|February 13, 2010
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaAndreana L Rivera, Christopher E Pelloski, Mark R Gilbert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Long-term anti-inflammatory and antihistamine medication use and adult glioma riskMichael E Scheurer, Randa El-Zein, Patricia A Thompson, et al.
Journal of Neuro-Oncology|May 20, 2015
Venous thromboembolism (VTE) and glioblastomaShlomit Yust-Katz, Jacob J Mandel, Jimin Wu, et al.
Brain Tumor Pathology|November 13, 2014
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcomaDavid Cachia, Khalida Wani, Marta Penas-Prado, et al.
Pageof 46

Showing results (191-200 of 453) with videos related to

Sort By:
Pageof 46
Leukemia & Lymphoma|June 5, 2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLakshmi Nayak, Lauren E Abrey, Jan Drappatz, et al.
Neuro-Oncology|June 3, 2024
Raman-based machine-learning platform reveals unique metabolic differences between IDHmut and IDHwt gliomaAdrian Lita, Joel Sjöberg, David Păcioianu, et al.
Neuro-Oncology Practice|August 7, 2019
Case-based review: ependymomas in adultsDavid Cachia, Derek R Johnson, Timothy J Kaufmann, et al.
Neuro-Oncology Practice|June 3, 2015
Personal health records, symptoms, uncertainty, and mood in brain tumor patientsJennifer E Cahill, Lin Lin, Geri LoBiondo-Wood, et al.
Journal of Neuro-Oncology|August 24, 2015
Wound healing complications in brain tumor patients on BevacizumabHarshad Ladha, Tushar Pawar, Mark R Gilbert, et al.
Neuro-Oncology|April 12, 2015
The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-ChronicTerri S Armstrong, Yuan Ying, Jimin Wu, et al.
Neuro-Oncology|February 13, 2010
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaAndreana L Rivera, Christopher E Pelloski, Mark R Gilbert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Long-term anti-inflammatory and antihistamine medication use and adult glioma riskMichael E Scheurer, Randa El-Zein, Patricia A Thompson, et al.
Journal of Neuro-Oncology|May 20, 2015
Venous thromboembolism (VTE) and glioblastomaShlomit Yust-Katz, Jacob J Mandel, Jimin Wu, et al.
Brain Tumor Pathology|November 13, 2014
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcomaDavid Cachia, Khalida Wani, Marta Penas-Prado, et al.
Pageof 46